FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988166297> ?p ?o ?g. }

• W1988166297 endingPage "6350" @default.
• W1988166297 startingPage "6345" @default.
• W1988166297 abstract "In vitro and in vivo models have been developed that have allowed for delineation of mechanisms of multiple myeloma (MM) cell homing to bone marrow (BM); tumor cell adhesion to extracellular matrix proteins and BM stromal cells; and cytokine-mediated growth, survival, drug resistance, and migration within the BM milieu. Delineation of the signaling cascades mediating these sequelae has identified multiple novel therapeutic targets in the tumor cell and its BM microenvironment. Importantly, novel therapies targeting the tumor cell and the BM, as well as those targeting the tumor cell or BM alone, can overcome the growth, survival, conventional drug resistance, and migration of MM cells bound to BM using both in vitro and in vivo severe combined immunodeficiency mouse models of human MM. These studies have translated rapidly from the bench to the bedside in derived clinical trials, and have already led to the United States Food and Drug Administration approval of the novel proteasome inhibitor bortezomib for treatment of relapsed/refractory MM. Novel agents will need to be combined to enhance cytotoxicity, avoid development of drug resistance, and allow for use of lower doses in combination therapies. Genomics, proteomics, and cell signaling studies have helped to identify in vivo mechanisms of sensitivity versus resistance to novel therapies, as well as aiding in the rational application of combination therapies. These studies have therefore provided the framework for a new treatment paradigm targeting the MM cell in its BM milieu to overcome drug resistance and improve patient outcome in MM." @default.
• W1988166297 created "2016-06-24" @default.
• W1988166297 creator A5006765393 @default.
• W1988166297 creator A5032464400 @default.
• W1988166297 creator A5043526996 @default.
• W1988166297 creator A5091207345 @default.
• W1988166297 date "2005-09-10" @default.
• W1988166297 modified "2023-10-04" @default.
• W1988166297 title "Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma" @default.
• W1988166297 cites W1759028523 @default.
• W1988166297 cites W1761234319 @default.
• W1988166297 cites W1968234852 @default.
• W1988166297 cites W1977348505 @default.
• W1988166297 cites W1980471295 @default.
• W1988166297 cites W1982224515 @default.
• W1988166297 cites W1985442655 @default.
• W1988166297 cites W1985906536 @default.
• W1988166297 cites W1986411954 @default.
• W1988166297 cites W1994418770 @default.
• W1988166297 cites W2001012146 @default.
• W1988166297 cites W2004441080 @default.
• W1988166297 cites W2007998678 @default.
• W1988166297 cites W2011485061 @default.
• W1988166297 cites W2016269970 @default.
• W1988166297 cites W2020793885 @default.
• W1988166297 cites W2023279835 @default.
• W1988166297 cites W2024969918 @default.
• W1988166297 cites W2025828169 @default.
• W1988166297 cites W2026742920 @default.
• W1988166297 cites W2032454178 @default.
• W1988166297 cites W2035298740 @default.
• W1988166297 cites W2039594026 @default.
• W1988166297 cites W2040252279 @default.
• W1988166297 cites W2043049816 @default.
• W1988166297 cites W2050431551 @default.
• W1988166297 cites W2055389088 @default.
• W1988166297 cites W2059838421 @default.
• W1988166297 cites W2059873406 @default.
• W1988166297 cites W2066936999 @default.
• W1988166297 cites W2067962862 @default.
• W1988166297 cites W2070739194 @default.
• W1988166297 cites W2072714194 @default.
• W1988166297 cites W2087263469 @default.
• W1988166297 cites W2092169550 @default.
• W1988166297 cites W2092646816 @default.
• W1988166297 cites W2093221289 @default.
• W1988166297 cites W2102401722 @default.
• W1988166297 cites W2104028456 @default.
• W1988166297 cites W2104148554 @default.
• W1988166297 cites W2104243547 @default.
• W1988166297 cites W2105997491 @default.
• W1988166297 cites W2106690941 @default.
• W1988166297 cites W2107154392 @default.
• W1988166297 cites W2108235071 @default.
• W1988166297 cites W2115180810 @default.
• W1988166297 cites W2119810076 @default.
• W1988166297 cites W2126866254 @default.
• W1988166297 cites W2131554133 @default.
• W1988166297 cites W2132258376 @default.
• W1988166297 cites W2133986577 @default.
• W1988166297 cites W2135709160 @default.
• W1988166297 cites W2137231887 @default.
• W1988166297 cites W2140639593 @default.
• W1988166297 cites W2142149038 @default.
• W1988166297 cites W2143894503 @default.
• W1988166297 cites W2144531125 @default.
• W1988166297 cites W2145882598 @default.
• W1988166297 cites W2145896029 @default.
• W1988166297 cites W2146502962 @default.
• W1988166297 cites W2149130352 @default.
• W1988166297 cites W2149386327 @default.
• W1988166297 cites W2152065071 @default.
• W1988166297 cites W2154374454 @default.
• W1988166297 cites W2154932260 @default.
• W1988166297 cites W2155330223 @default.
• W1988166297 cites W2158414356 @default.
• W1988166297 cites W2162537424 @default.
• W1988166297 cites W2162628305 @default.
• W1988166297 cites W2162934657 @default.
• W1988166297 cites W2165801057 @default.
• W1988166297 cites W2168268910 @default.
• W1988166297 cites W2169210465 @default.
• W1988166297 cites W2169295136 @default.
• W1988166297 cites W2169508075 @default.
• W1988166297 cites W2170192548 @default.
• W1988166297 cites W2171706918 @default.
• W1988166297 cites W2280837071 @default.
• W1988166297 cites W2568732726 @default.
• W1988166297 cites W95158608 @default.
• W1988166297 doi "https://doi.org/10.1200/jco.2005.05.024" @default.
• W1988166297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16155018" @default.
• W1988166297 hasPublicationYear "2005" @default.
• W1988166297 type Work @default.
• W1988166297 sameAs 1988166297 @default.
• W1988166297 citedByCount "69" @default.
• W1988166297 countsByYear W19881662972012 @default.
• W1988166297 countsByYear W19881662972013 @default.
• W1988166297 countsByYear W19881662972014 @default.

• next